Registered entities
Pathogendx, Inc
Reg. No. 47-2362135United States
Innovation
22 patent families (10 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 472 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 13 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 2 |
Social engagement
Social engagement: 2.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Entourage Effect Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 2 | 17% |
| Other / undisclosed | 3 | 25% |
Recent activity
4 Jun 2026
Product launch
SeroX from PathogenDx
6 Feb 2026
Event
IPPE
29 Jan 2026
Event
IPPE